Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuyue Lei

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|June 10, 2026
Design, Synthesis, and Pharmacological Evaluation of cGAS/HDAC Dual Inhibitors for Treatment of Autoimmune DiseasesZihua Zhou, Mingjie Chen, Shuyue Lei, et al.
ACS Pharmacology & Translational Science|March 19, 2026
Cathepsin B‑Responsive Phosphatidylinositol 3‑Kinase (PI3K) Prodrug for the Treatment of Pulmonary FibrosisXiaomei Li, Tao Yang, Shuyue Lei, et al.
Journal of Ethnopharmacology|December 4, 2023
The anti-hyperlipidemic effects of Poria cocos (Schw.) Wolf extract: Modulating cholesterol homeostasis in hepatocytes via PPARα pathwayXinyu Zhang, Wei Lin, Shuyue Lei, et al.
European Journal of Pharmacology|March 2, 2026
PDE4 inhibitor DC591017 ameliorates pulmonary fibrosis through modulating fibroblasts-epithelial cells-alternatively activated macrophages crosstalkShuyue Lei, Jian Li, Tao Yang, et al.
Journal of Medicinal Chemistry|April 15, 2024
Design, Synthesis, and Pharmacological Evaluation of Spiro[carbazole-3,3'-pyrrolidine] Derivatives as cGAS Inhibitors for Treatment of Acute Lung InjuryMingjie Chen, Shuyue Lei, Zihua Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 19, 2026
RIPK3 Orchestrates Scar-Associated Macrophage Dysfunction to Drive Pulmonary FibrosisTao Yang, Xiao Li, Shuyue Lei, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|June 10, 2026
Design, Synthesis, and Pharmacological Evaluation of cGAS/HDAC Dual Inhibitors for Treatment of Autoimmune DiseasesZihua Zhou, Mingjie Chen, Shuyue Lei, et al.
ACS Pharmacology & Translational Science|March 19, 2026
Cathepsin B‑Responsive Phosphatidylinositol 3‑Kinase (PI3K) Prodrug for the Treatment of Pulmonary FibrosisXiaomei Li, Tao Yang, Shuyue Lei, et al.
Journal of Ethnopharmacology|December 4, 2023
The anti-hyperlipidemic effects of Poria cocos (Schw.) Wolf extract: Modulating cholesterol homeostasis in hepatocytes via PPARα pathwayXinyu Zhang, Wei Lin, Shuyue Lei, et al.
European Journal of Pharmacology|March 2, 2026
PDE4 inhibitor DC591017 ameliorates pulmonary fibrosis through modulating fibroblasts-epithelial cells-alternatively activated macrophages crosstalkShuyue Lei, Jian Li, Tao Yang, et al.
Journal of Medicinal Chemistry|April 15, 2024
Design, Synthesis, and Pharmacological Evaluation of Spiro[carbazole-3,3'-pyrrolidine] Derivatives as cGAS Inhibitors for Treatment of Acute Lung InjuryMingjie Chen, Shuyue Lei, Zihua Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 19, 2026
RIPK3 Orchestrates Scar-Associated Macrophage Dysfunction to Drive Pulmonary FibrosisTao Yang, Xiao Li, Shuyue Lei, et al.
Pageof 1